Tag: Pierre
European Commission nod for Pierre Fabre Braftovitovi
Pierre Fabre Laboratories announced that the European Commission (EC) has approved Braftovitovi (encorafenib) in combination with Mektovi (binimetinib) for the treatment of adult patients...
Pierre Fabre Laboratories receives CHMP positive opinion for Braftovi in combination...
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending the approval of Braftovi (encorafenib)...